My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 250

    1.

    Prevention and treatment of obesity, insulin resistance, and diabetes by bile acid-binding resin.

    Kobayashi M, Ikegami H, Fujisawa T, Nojima K, Kawabata Y, Noso S, Babaya N, Itoi-Babaya M, Yamaji K, Hiromine Y, Shibata M, Ogihara T.

    Diabetes. 2007 Jan;56(1):239-47.PMID: 17192488 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Effect of colestimide therapy for glycemic control in type 2 diabetes mellitus with hypercholesterolemia.

    Yamakawa T, Takano T, Utsunomiya H, Kadonosono K, Okamura A.

    Endocr J. 2007 Feb;54(1):53-8. Epub 2006 Nov 14.PMID: 17102570 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Effects of rosuvastatin and colestimide on metabolic parameters and urinary monocyte chemoattractant protein-1 in type 2 diabetic patients with hyperlipidemia.

    Takebayashi K, Suetsugu M, Matsumoto S, Aso Y, Inukai T.

    South Med J. 2009 Apr;102(4):361-8.PMID: 19279518 [PubMed - indexed for MEDLINE]Related articles

    4.

    Blood glucose-lowering activity of colestimide in patients with type 2 diabetes and hypercholesterolemia: a case-control study comparing colestimide with acarbose.

    Suzuki T, Oba K, Futami S, Suzuki K, Ouchi M, Igari Y, Matsumura N, Watanabe K, Kigawa Y, Nakano H.

    J Nippon Med Sch. 2006 Oct;73(5):277-84.PMID: 17106179 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Novel pathways for glycaemic control in type 2 diabetes: focus on bile acid modulation.

    Brinton EA.

    Diabetes Obes Metab. 2008 Nov;10(11):1004-11. Epub 2008 May 20. Review.PMID: 18494807 [PubMed - indexed for MEDLINE]Related articles

    6.

    Effects of colestimide on blood glucose-lowering activity and body weight in patients with type 2 diabetes and hypercholesterolemia.

    Suzuki T, Oba K, Futami-Suda S, Suzuki K, Ouchi M, Igari Y, Matsumura N, Watanabe K, Kigawa Y, Nakano H.

    J Nippon Med Sch. 2007 Feb;74(1):81-4. No abstract available. PMID: 17384485 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Effects of colestimide and/or Bofu-tsusho-san on plasma and liver lipids in mice fed a high-fat diet.

    Sakamoto S, Takeshita S, Sassa S, Suzuki S, Ishikawa Y, Kudo H.

    In Vivo. 2005 Nov-Dec;19(6):1029-33.PMID: 16277017 [PubMed - indexed for MEDLINE]Related articles

    8.

    Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice.

    Liu LF, Purushotham A, Wendel AA, Belury MA.

    Am J Physiol Gastrointest Liver Physiol. 2007 Jun;292(6):G1671-82. Epub 2007 Feb 22.PMID: 17322064 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Phloridzin improves hyperglycemia but not hepatic insulin resistance in a transgenic mouse model of type 2 diabetes.

    Zhao H, Yakar S, Gavrilova O, Sun H, Zhang Y, Kim H, Setser J, Jou W, LeRoith D.

    Diabetes. 2004 Nov;53(11):2901-9.PMID: 15504971 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Drug-induced effects on cholesterol catabolism and bile acids.

    Gylling H, Miettinen TA.

    Curr Opin Investig Drugs. 2006 Mar;7(3):214-8. Review.PMID: 16555681 [PubMed - indexed for MEDLINE]Related articles

    11.

    Synthetic protease inhibitor camostat prevents and reverses dyslipidemia, insulin secretory defects, and histological abnormalities of the pancreas in genetically obese and diabetic rats.

    Jia D, Taguchi M, Otsuki M.

    Metabolism. 2005 May;54(5):619-27.PMID: 15877292 [PubMed - indexed for MEDLINE]Related articles

    12.

    A role for atorvastatin and insulin combination in protecting from liver injury in a model of type 2 diabetes with hyperlipidemia.

    Matafome P, Nunes E, Louro T, Amaral C, Crisóstomo J, Rodrigues L, Moedas AR, Monteiro P, Cipriano A, Seiça R.

    Naunyn Schmiedebergs Arch Pharmacol. 2009 Mar;379(3):241-51. Epub 2008 Oct 21.PMID: 18936912 [PubMed - indexed for MEDLINE]Related articles

    13.

    Bile acid sequestrants and the treatment of type 2 diabetes mellitus.

    Staels B, Kuipers F.

    Drugs. 2007;67(10):1383-92. Review.PMID: 17600387 [PubMed - indexed for MEDLINE]Related articles

    14.

    Diazoxide prevents abdominal adiposity and fatty liver in obese OLETF rats at prediabetic stage.

    Guo Z, Bu S, Yu Y, Ghatnekar G, Wang M, Chen L, Bu M, Yang L, Zhu B, Feng Z, Huang Q.

    J Diabetes Complications. 2008 Jan-Feb;22(1):46-55.PMID: 18191077 [PubMed - indexed for MEDLINE]Related articles

    15.

    [Pharmacological therapy of obesity]

    Pagotto U, Vanuzzo D, Vicennati V, Pasquali R.

    G Ital Cardiol (Rome). 2008 Apr;9(4 Suppl 1):83S-93S. Italian. PMID: 18773755 [PubMed - indexed for MEDLINE]Related articles

    16.

    Role of the fatty acid binding protein mal1 in obesity and insulin resistance.

    Maeda K, Uysal KT, Makowski L, Görgün CZ, Atsumi G, Parker RA, Brüning J, Hertzel AV, Bernlohr DA, Hotamisligil GS.

    Diabetes. 2003 Feb;52(2):300-7.PMID: 12540600 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Small-molecule insulin mimetic reduces hyperglycemia and obesity in a nongenetic mouse model of type 2 diabetes.

    Strowski MZ, Li Z, Szalkowski D, Shen X, Guan XM, Jüttner S, Moller DE, Zhang BB.

    Endocrinology. 2004 Nov;145(11):5259-68. Epub 2004 Aug 5.PMID: 15297448 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Nonobese, insulin-deficient Ins2Akita mice develop type 2 diabetes phenotypes including insulin resistance and cardiac remodeling.

    Hong EG, Jung DY, Ko HJ, Zhang Z, Ma Z, Jun JY, Kim JH, Sumner AD, Vary TC, Gardner TW, Bronson SK, Kim JK.

    Am J Physiol Endocrinol Metab. 2007 Dec;293(6):E1687-96. Epub 2007 Oct 2.PMID: 17911348 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Reducing cardiovascular complications of type 2 diabetes by targeting multiple risk factors.

    Reasner CA.

    J Cardiovasc Pharmacol. 2008 Aug;52(2):136-44. Review.PMID: 18670366 [PubMed - indexed for MEDLINE]Related articles

    20.

    [Mode of action of benfluorex. Recent data]

    Brindley DN.

    Presse Med. 1992 Sep 9;21(28):1330-5. Review. French. PMID: 1438102 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity